申请人:——
公开号:US06511993B1
公开(公告)日:2003-01-28
Compounds of formula (I) and pharmaceutically-acceptable derivatives thereof, are matrix metalloprotease inhibitors, useful in treatment of conditions mediated by matrix metalloproteases, such as chronic dermal ulcers.
公式(I)的化合物及其药用可接受的衍
生物是基质
金属蛋白酶抑制剂,在治疗由基质
金属
蛋白酶介导的疾病,如慢性皮肤溃疡方面有用。